UBS’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2014
Q3 | $2.08M | Buy |
174,874
+79,520
| +83% | +$948K | ﹤0.01% | 2174 |
|
|
2014
Q2 | $537K | Buy |
95,354
+50,904
| +115% | +$287K | ﹤0.01% | 3132 |
|
|
2014
Q1 | $163K | Sell |
44,450
-1,324
| -3% | -$4.86K | ﹤0.01% | 3862 |
|
|
2013
Q4 | $154K | Sell |
45,774
-171,968
| -79% | -$579K | ﹤0.01% | 3786 |
|
|
2013
Q3 | $921K | Buy |
217,742
+90,372
| +71% | +$382K | ﹤0.01% | 2525 |
|
|
2013
Q2 | $586K | Buy |
+127,370
| New | +$586K | ﹤0.01% | 2774 |
|